Back to search

Article

Anlotinib plus Temozolomide for Recurrent Glioma: A Single-Center, Retrospective Study of 30 cases

2024-05-20

Abstract excerpt

<title>Abstract</title> <p>Objective To determine the efficacy and tolerability of Anlotinib plus temozolomide (TMZ) as a first-line treatment for recurrent malignant glioma (rMG). Methods A total of 30 eligible patients who relapsed from the standard chemoradiotherapy regimen (TMZ and radiotherapy) or had macroscopic residual tumor after surgery because of tumor located in the eloquent brain areas were enrolle...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0b62a377-7266-5449-b509-81c2dfe1ad80
DOI
10.21203/rs.3.rs-4373518/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Anlotinib plus Temozolomide for Recurrent Glioma: A Single-Center, Retrospective Study of 30 casesDOI 10.21203/rs.3.rs-4373518/v1
Targeted and Systemic therapies for recurrent adult ependymomas: real- world outcomes from a single institution and concise literature reviewSemantic proximity
Very Late Recurrence of Glioblastoma after 8 Years of Progression-Free Survival: A Case Report and Review of Tumor DormancySemantic proximity
Very Late Recurrence of Glioblastoma after 8 Years of Progression-Free Survival: A Case Report and Review of Tumor DormancySemantic proximity
Afatinib, an irreversible ErbB family blocker, with protracted temozolomide in recurrent glioblastoma: a case report.Semantic proximity
Recurrence patterns and clinical outcomes in adult cerebellar glioblastomaSemantic proximity
Survival analysis of radiotherapy alone versus radiotherapy combined with temozolomide chemotherapy for low-grade gliomas: a meta-analysisSemantic proximity
Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent GliomaSemantic proximity
Predictive value of EGFR amplification and EGFRvIII mutation in EGFR-targeted therapy for recurrent glioblastoma: a systematic review.Semantic proximity
The safety and efficacy of dabrafenib and trametinib in patients with glioma: A systematic review and meta-analysis.Semantic proximity
Intratumor heterogeneity, microenvironment, and mechanisms of drug resistance in glioma recurrence and evolution.Semantic proximity
An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting.Semantic proximity
Radiomics improves the prognosis assessment of glioma recurrences: Focus on reliability analysis of MRI featuresSemantic proximity
Select a neighboring publication to make it the new centre.